[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569544":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":25,"studyPopulation":16,"armGroups":26,"interventions":37,"overallOfficials":43,"centralContacts":48,"locations":16,"responsibleParty":53,"collaborators":16,"id":56,"slug":16,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":16,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":16,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":79,"whyStopped":16,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":16},{"fullName":5,"class":6},"Umraniye Education and Research Hospital","OTHER_GOV",{"primaryOutcomes":8,"secondaryOutcomes":16,"otherOutcomes":16},[9,13],{"measure":10,"description":11,"timeFrame":12},"visual analogue scale","Zero is equivalent to no pain and 10 indicates the worst possible pain.","24 hours",{"measure":14,"description":15,"timeFrame":12},"total amount of tramadol consumption","Total tramadol consumption will be recorded in the postoperative period by fitting participants with a patient-controlled analgesia device.",null,{"allocation":18,"interventionModel":19,"interventionModelDescription":16,"primaryPurpose":20,"observationalModel":16,"timePerspective":16,"maskingInfo":21},"RANDOMIZED","PARALLEL","SUPPORTIVE_CARE",{"masking":22,"maskingDescription":16,"whoMasked":23},"SINGLE",[24],"PARTICIPANT","This randomised controlled study will be conducted in Umraniye Training and Research Hospital operating room between November 2024 and January 2025 after obtaining ethics committee and patient consent. Each patient will be informed about the procedures to be performed during anaesthesia and surgery and signed informed consent will be obtained before the procedure. Patients will undergo septoplasty by the same otolaryngology team.\n\nA total of 50 participants (25 envelopes each with Group 1 and Group 2 written inside) will be kept closed for the patients participating in the study. Upon the patient's fulfilment of the conditions suitable for the study, it will be randomly determined which group he\u002Fshe will be included in. Thanks to this randomisation, conscious or unconscious manipulations in the selection of patients to the study group will be prevented.",[27,33],{"label":28,"type":29,"description":30,"interventionNames":31},"group with sphenopalatine ganglion block","ACTIVE_COMPARATOR","Sphenopalatine ganglion block will be performed for participants undergoing septoplasty.",[32],"Procedure: Sphenopalatine Ganglion Block",{"label":34,"type":35,"description":36,"interventionNames":16},"group without sphenopalatine ganglion block","NO_INTERVENTION","Sphenopalatine ganglion block will not be performed for participants undergoing septoplasty",[38],{"type":39,"name":40,"description":41,"armGroupLabels":42,"otherNames":16},"PROCEDURE","Sphenopalatine Ganglion Block","Sphenopalatine ganglion block group 4cc (80mg) 2% lidocaine + 1cc (4mg) dexamethasone in total 5cc volume will be prepared under sterile conditions before the procedure, 2.5 cc will be given to both nostrils. Sphenopalatine ganglion block will be applied by transnasal endoscopic method.",[28],[44],{"name":45,"affiliation":46,"role":47},"şenay göksu, MD","Umraniye Education and Research Hospital Collaborators:","PRINCIPAL_INVESTIGATOR",[49],{"name":45,"role":50,"phone":51,"phoneExt":16,"email":52},"CONTACT","905337144852","senaytomruk@hotmail.com",{"type":47,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":16,"oldOrganization":16},"Senay Goksu","specialist doctor","100569544",false,"NCT06695624","Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block on Postoperative Pain After Septoplasty","Investigation of the Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block in Management of Postoperative Pain After Septoplasty","Inclusion Criteria:\n\n* Participants who will undergo septoplasty\n* 18 to 50 years old\n* ASA score 1 or 2\n\nExclusion Criteria:\n\n* Under 18 or over 50 years of age\n* ASA score III and above patient group\n* The patient is allergic to any of the drugs used\n* The patient has a contraindication to any of the drugs used\n* Use of anticoagulant medication\n* Failure of the patient to give consent\n* Being pregnant\n* Those with GCS retardation such as dementia, mental retardation\n* Those with diagnosed headache",true,"ALL","18 Years","50 Years",{"count":67,"type":68},50,"ESTIMATED","INTERVENTIONAL",[71],"NA","The aim of this clinical study will investigate the efficacy of sphenopalatine ganglion block in the treatment of postoperative pain.it will also be learnt whether it reduces the consumption of analgesics in postoperative pain.The main questions it aims to answer are:\n\nWill the participants' need for painkillers decrease after the operation? Can sphenopalatine ganglion block be used for postoperative pain after septoplasty? The researchers will compare 2 groups with and without sphenopalatine ganglion block to see the effectiveness of sphenopalatine ganglion block.\n\nParticipants will:\n\nRead the information Participants have been given about the sphenopalatine ganglion block.\n\nIn case of any side effects, please contact participant's doctor.",[74],"Postoperative Pain",[76,77,78],"sphenopalatine ganglion block","septoplasty","postoperative pain","NOT_YET_RECRUITING","2024-11-15",{"date":82,"type":83},"2024-11-19","ACTUAL",{"date":85,"type":68},"2024-11",{"date":87,"type":68},"2025-01",{"name":5,"class":6}]